SU1453661A1 - Противоопухолевое средство "продимин - Google Patents
Противоопухолевое средство "продимин Download PDFInfo
- Publication number
- SU1453661A1 SU1453661A1 SU721848995A SU1848995A SU1453661A1 SU 1453661 A1 SU1453661 A1 SU 1453661A1 SU 721848995 A SU721848995 A SU 721848995A SU 1848995 A SU1848995 A SU 1848995A SU 1453661 A1 SU1453661 A1 SU 1453661A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- patients
- treatment
- drug
- course
- patient
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU721848995A SU1453661A1 (ru) | 1972-11-17 | 1972-11-17 | Противоопухолевое средство "продимин |
GB4001273A GB1428044A (en) | 1972-11-17 | 1973-08-23 | Antitumorigenic compositions |
DE19732343809 DE2343809A1 (de) | 1972-11-17 | 1973-08-30 | Arzneimittel mit antigeschwulstwirkung |
FR7339101A FR2206938B1 (US20100223739A1-20100909-C00005.png) | 1972-11-17 | 1973-11-02 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU721848995A SU1453661A1 (ru) | 1972-11-17 | 1972-11-17 | Противоопухолевое средство "продимин |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1453661A1 true SU1453661A1 (ru) | 1989-10-30 |
Family
ID=20532792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU721848995A SU1453661A1 (ru) | 1972-11-17 | 1972-11-17 | Противоопухолевое средство "продимин |
Country Status (4)
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2456983C2 (ru) * | 2006-11-28 | 2012-07-27 | Новартис Аг | Комбинация ингибиторов iap и flt3 |
RU2605603C1 (ru) * | 2015-06-19 | 2016-12-27 | Федеральное государственное бюджетное учреждение науки Институт проблем химической физики Российской академии наук (ИПХФ РАН) | N,n'-бис(3-бромпропионил)-n,n'-диметил-1,2-этилендиамин, способ его получения и применение его в качестве водорастворимого реагента, проявляющего противоопухолевые свойства |
-
1972
- 1972-11-17 SU SU721848995A patent/SU1453661A1/ru active
-
1973
- 1973-08-23 GB GB4001273A patent/GB1428044A/en not_active Expired
- 1973-08-30 DE DE19732343809 patent/DE2343809A1/de active Pending
- 1973-11-02 FR FR7339101A patent/FR2206938B1/fr not_active Expired
Non-Patent Citations (1)
Title |
---|
Prod.et probl.pharm., , № 4, р,276. * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2456983C2 (ru) * | 2006-11-28 | 2012-07-27 | Новартис Аг | Комбинация ингибиторов iap и flt3 |
RU2605603C1 (ru) * | 2015-06-19 | 2016-12-27 | Федеральное государственное бюджетное учреждение науки Институт проблем химической физики Российской академии наук (ИПХФ РАН) | N,n'-бис(3-бромпропионил)-n,n'-диметил-1,2-этилендиамин, способ его получения и применение его в качестве водорастворимого реагента, проявляющего противоопухолевые свойства |
Also Published As
Publication number | Publication date |
---|---|
GB1428044A (en) | 1976-03-17 |
FR2206938B1 (US20100223739A1-20100909-C00005.png) | 1977-02-18 |
DE2343809A1 (de) | 1974-06-06 |
FR2206938A1 (US20100223739A1-20100909-C00005.png) | 1974-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Creagan et al. | Phase II study of recombinant leukocyte A interferon (rIFN‐αA) in disseminated malignant melanoma | |
Robinson et al. | Treatment of metastatic malignant melanoma with recombinant interferon alpha 2 | |
Poplack et al. | Phase I study of 2′-deoxycoformycin in acute lymphoblastic leukemia | |
Dover et al. | Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production | |
Allen et al. | Oxymetholone therapy in aplastic anemia | |
EP0774255B1 (en) | Use of ursolic acid for the manufacture of a medicament for suppressing metastasis | |
Teklu et al. | Meptazinol diminishes the Jarisch-Herxheimer reaction of relapsing fever | |
Sokal et al. | Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia | |
EP0821963A1 (en) | Anticancer substance suppressing cancerous metastasis | |
US4806347A (en) | Interferon combinations | |
Sikora | Does interferon cure cancer? | |
Nissen et al. | Phase I Clinical Trial of an Oral Solution of VP-16-2131, 2 | |
SU1453661A1 (ru) | Противоопухолевое средство "продимин | |
PT99265B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo interferon humano e metodo de tratamento de doencas proliferativas celulares | |
Martoni et al. | Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer | |
Talpaz et al. | Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis | |
Herman | Effect of Temperature on the Cytotoxicity of Vindesine, Amsacrine, and Mitoxantrone¹, 2 | |
Shimkin et al. | Trisethylene-imino-s-triazine (triethylene melamine or TEM) in the treatment of neoplastic diseases | |
Bershof et al. | AGRANULOCYTOSIS FOLLOWING USE OF PHENYLBUTAZONE (BUTAZOLIDIN9): REPORT OF A CASE | |
DE4127469A1 (de) | Arzneimittel und ihre verwendung | |
CN114650826A (zh) | 一种多靶点蛋白激酶抑制剂的用途 | |
Suzuki et al. | Pure white cell aplasia complicated by systemic sclerosis with accompanying scleroderma renal crisis | |
CA2229141A1 (en) | Combination therapy for advanced cancer comprising temozolomide and cisplatin | |
Epstein | Synthetic antimalarial drug therapy in lupus erythematosus and polymorphous light eruptions | |
Brodsky et al. | Effect of testosterone enanthate and alkylating agents on multiple myeloma |